Loading...
Postoperative Bio-Chemoradiotherapy Using Cetuximab and Docetaxel in Patients With Cis-Platinum–Intolerant Core High-Risk Head and Neck Cancer: Protocol of a Phase 2 Nonrandomized Clinical Trial
BACKGROUND: We confirmed the safety of postoperative bio-chemoradiotherapy using cetuximab and docetaxel in a small number of patients with cis-platinum–intolerant core high-risk head and neck cancer. OBJECTIVE: To assess treatment efficacy, we planned a phase 2 study of postoperative bio-chemoradio...
Na minha lista:
| Udgivet i: | JMIR Res Protoc |
|---|---|
| Main Authors: | , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
JMIR Publications
2018
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6127497/ https://ncbi.nlm.nih.gov/pubmed/30139721 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2196/11003 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|